Every SEC Form 3/4/5 on record for this filer (CIK 1823563) — 4 issuers, 58 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| VCYT | VERACYTE, INC. | Chief Financial Officer | 2021-07-20 → 2026-06-04 | 30 | −$3M |
| ALMR | Alamar Biosciences, Inc. | Director | 2026-04-16 → 2026-04-20 | 2 | — |
| NARI | Inari Medical, Inc. | Director | 2021-06-22 → 2025-02-19 | 8 | −$55,713 |
| OM | Outset Medical, Inc. | Chief Financial Officer · lapsed | 2020-09-14 → 2021-06-25 | 7 | −$3M |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| VCYT | 2026-06-04 | Sell | 1,961 | $50.09 | $98,226 | 173,280 |
| VCYT | 2026-06-04 | Sell | 1,600 | $49.28 | $78,848 | 175,241 |
| VCYT | 2026-03-04 | Sell | 4,400 | $35.55 | $156,420 | 145,137 |
| VCYT | 2026-03-04 | Sell | 13,941 | $36.33 | $506,477 | 131,196 |
3 of 4 issuers are covered and open a security page; the rest are on file here only.
